ZSAN - ゾサノ・ファ―マ (Zosano Pharma Corporation) ゾサノ・ファ―マ

 ZSANのチャート


 ZSANの企業情報

symbol ZSAN
会社名 Zosano Pharma Corp (ゾサノ・ファ―マ)
分野(sector) Health Care   ヘルスケア
産業(industry) Major Pharmaceuticals  
業種 バイオテクノロジ―_メディカルリサ―チ   医療関連(Health Care)
概要 事業概要 ゾサノ・ファーマー(Zosano Pharma Corporation)は臨床段階の特殊医薬品会社。同社は、各種適応症の治療のために皮膚を介して既存の薬物のその製剤を提供するために、経皮マイクロニードルパッチシステムを開発した。そのマイクロニードルパッチシステムは、商業市場におけるさまざまな適応症の多数の薬物を送達する可能性を有する。その短い摩耗時の経皮パッチは、既存の薬物のその処方でコーティングし、接着剤のパッチに添付されたチタンマイクロニードルの配列で構成されます。同社のリード製品候補とその扱い適応症は、重度の骨粗しょう症のためのWeekly ZP-PTH、重度の低血糖のためのZP-Glucagon、片頭痛のためのZP-Triptanを含む。平成26年1月、同社はマイクロニードルパッチ製品を開発ために、Novo Nordisk A/S (Novo Nordisk)と戦略的パートナーシップおよびライセンス契約を締結した。   ゾサノ・ファ―マは米国の臨床段階の医薬品会社。治療薬物を多数の微小突起を介して皮膚表皮に浸透させることによる、経皮的微小突起薬物送達システムを開発。このシステムを利用した経皮製剤は、薬物が被覆された微小突起が配置された薄膜(アレイ)が装着された粘着性パッチと、再利用可能なアプリケ―タから構成される。本社はカリフォルニア州。   Zosano Pharma Corporation is a clinical-stage biopharmaceutical company focused on developing products where rapid administration of approved molecules with established safety and efficacy profiles may provide substantial benefit to patients, in markets where patients remain underserved by existing therapies. The company's transdermal microneedle system technology consists of titanium microneedles coated with drug that are designed to enable rapid systemic administration of therapeutics to patients. Zosano's lead product candidate is Qtrypta™ (M207), which is a proprietary formulation of zolmitriptan designed to be delivered via its transdermal microneedle system technology, as an acute treatment for migraine.
本社所在地 34790 Ardentech Court Fremont CA 94555 USA
代表者氏名 John P. Walker ジョンP.ウォーカー
代表者役職名 Chairman of the Board President Chief Executive Officer 取締役会長兼最高経営責任者(CEO)
電話番号 +1 510-745-1200
設立年月日 40909
市場名 NASDAQ Small Cap
ipoyear 2015年
従業員数 38人
url www.zosanopharma.com
nasdaq_url https://www.nasdaq.com/symbol/zsan
adr_tso
EBITDA EBITDA(百万ドル) -30.20100
終値(lastsale) 4.16
時価総額(marketcap) 49807842.24
時価総額 時価総額(百万ドル) 47.05404
売上高 売上高(百万ドル) 0.00000
企業価値(EV) 企業価値(EV)(百万ドル) 13.01604
当期純利益 当期純利益(百万ドル) -32.40400
決算概要 決算概要 BRIEF: For the six months ended 30 June 2018 Zosano Pharma Corp revenues was not reported. Net loss increased 24% to $17M. Higher net loss reflects Other income decrease of 70% to $3K (income). Basic Earnings per Share excluding Extraordinary Items increased from -$9.22 to -$4.91.

 ZSANのテクニカル分析


 ZSANのニュース

   Zosano Pharma Corporation (NASDAQ: ZSAN) Is Down -27.56% – Is It Capable Of A Rally?  2022/06/07 11:00:00 Stocks Register
Zosano Pharma Corporation (NASDAQ:ZSAN) traded at $0.56 at close of the session on Monday, 06/06/22, made a downward move of -27.56% on its previous day’s price. Looking at the stock we see that its previous close was $0.78 and the beta (5Y monthly) reads 3.29 with the day’s price range being $0.565 – $0.72. In … Zosano Pharma Corporation (NASDAQ: ZSAN) Is Down -27.56% – Is It Capable Of A Rally? Read More »
   ADAP, SLDP and ZSAN among mid-day movers  2022/06/03 16:42:11 Seeking Alpha
Gainers: Turning Point Therapeutics TPTX +117%.Energy Focus EFOI +40%.Galecto GLTO +25%.Adaptimmune (ADAP) +22%.Amylyx Pharmaceuticals AMLX +22%.AudioEye AEYE +20%.Sprague Resources…
   US stocks closed higher, Dow Jones up 1.33%  2022/06/03 03:12:40 InstaForex
At the close of the New York Stock Exchange, the Dow Jones rose 1.33%, the S&P 500 rose 1.84% and the NASDAQ Composite index rose 2.69%. Boeing Co was the top gainer among the components of the Dow Jones in today''s trading, up 9.85 points or 7.54% to close at 140.50. Salesforce.com Inc rose 12.33 points or 7.00% to close at 188.40. Nike Inc rose 4.73 points or 3.99% to close at 123.41. The biggest losers were Amgen Inc, which shed 5.14 points or 2.03% to end the session at 248.28. Merck & Company Inc. shares rose 1.14 points (1.25%) to close at 90.00, while Johnson & Johnson shed 0.56 points (0.32%) to close at 177.15. The leaders of gains among the components of the S&P 500 in today''s trading were General Holdings Inc, which rose 10.29% to 268.95, SolarEdge Technologies Inc, which gained 10.28% to close at 300.49, and also shares of DexCom Inc, which rose 9.86% to end the session at 311.83. The biggest losers were Hormel Foods Corporation, which shed 5.22% to close at 45.76. Shares of Hewlett Packard Enterprise Co lost 5.20% to end the session at 14.96.
   Why Zosano Pharma Shares Are Getting Hammered Today  2022/06/02 18:42:03 Benzinga
Zosano Pharma Corp (NASDAQ: ZSAN ) shares are trading lower by 44.35% at $0.98 after the company announced it filed a voluntary petition for relief under chapter 11. Zosano says the company continues to operate its business as a "debtor-in-possession" under the … Full story available on Benzinga.com
   Migraine Patch Developer Zosano Goes Bankrupt, Will Sell Assets - BNN Bloomberg  2022/06/02 14:54:34 BNN Bloomberg
Zosano Pharma Corp., a publicly traded developer of a migraine treatment patch, filed for Chapter 11 bankruptcy with plans to sell its assets.
   Zosano Pharma Corporation (NASDAQ: ZSAN) Is One Of The Hottest Stocks Right Now.  2022/03/22 13:00:00 Stocks Register
Zosano Pharma Corporation (NASDAQ:ZSAN) price closed higher on Monday, March 21, jumping 20.28% above its previous close. >> 5 Best Growth Stocks for 2022 << >> 5 Best Growth Stocks for 2022 << A look at the daily price movement shows that the last close reads $0.18, with intraday deals fluctuated between $0.178 and $0.228. … Zosano Pharma Corporation (NASDAQ: ZSAN) Is One Of The Hottest Stocks Right Now. Read More »
   Zosano Lays Off ~30% Of Its Workforce After FDA Rejection Of Migraine Drug Application  2022/03/18 15:27:15 Benzinga
Zosano Pharma Corp (NASDAQ: ZSAN ) is looking at strategic alternatives and reduced 31% of its staff as the FDA rejected its already-rejected migraine drug last month. M207, known as Qtrypta, includes a new delivery system for migraine drug triptan zolmitriptan. But Zosano''s
   Zosano Pharma GAAP EPS of -$0.06 misses by $0.02, revenue of $0.09M misses by $1.39M (NASDAQ:ZSAN)  2022/03/17 21:02:10 Seeking Alpha
Zosano Pharma press release (ZSAN): Q4 GAAP EPS of -$0.06 misses by $0.02.Revenue of $0.09M (-59.1% Y/Y) misses by $1.39M.Shares -3.82% AH.As of December 31, 2021, cash and…
   Zosano Pharma Reports Fourth Quarter and Fiscal Year 2021 Financial Results  2022/03/17 20:05:00 GlobeNewswire
FREMONT, Calif., March 17, 2022 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical-stage biopharmaceutical company, today announced financial results for the fourth quarter and year ended December 31, 2021, as well as business updates.
   Shares Of Zosano Pharma Corporation (NASDAQ: ZSAN) Could Show A Loss Of -1150.0%  2022/03/08 12:00:00 Marketing Sentinel
In the last trading session, 8.75 million shares of the Zosano Pharma Corporation (NASDAQ:ZSAN) were traded, and its beta was 2.91. Most recently the company’s share price was $0.16, and it changed around -$0.01 or -6.17% from the last close, which brings the market valuation of the company to $29.09M. ZSAN currently trades at a … Shares Of Zosano Pharma Corporation (NASDAQ: ZSAN) Could Show A Loss Of -1150.0% Read More »
   Zosano Pharma Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)  2021/11/30 02:45:00 Intrado Digital Media
FREMONT, Calif., Nov. 29, 2021 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical-stage biopharmaceutical company, today announced that the Board of Directors granted a stock option to purchase 220,000 shares of Zosanos common stock to a new employee as an inducement award.
   Have a grip on this: Zosano Pharma Corporation (NASDAQ:ZSAN), Secoo Holding Limited (NASDAQ:SECO)  2021/11/29 03:54:00 Stock Equity
Zosano Pharma Corporation (ZSAN) with the stream of -0.50% also noticed, India Secoo Holding Limited (SECO) encountered a rapid change of -5.54% in the last hour of trading session. Zosano The post Have a grip on this: Zosano Pharma Corporation (NASDAQ:ZSAN), Secoo Holding Limited (NASDAQ:SECO) appeared first on Stocks Equity .
   Head-To-Head Survey: Tenax Therapeutics (NASDAQ:TENX) & Zosano Pharma (NASDAQ:ZSAN)  2021/11/28 00:44:41 Dakota Financial News
Tenax Therapeutics (NASDAQ:TENX) and Zosano Pharma (NASDAQ:ZSAN) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their earnings, profitability, institutional ownership, analyst recommendations, valuation, dividends and risk. Profitability This table compares Tenax Therapeutics and Zosano Pharmas net margins, return on equity and []
   Stock on the Move: Zosano Pharma Corporation (NASDAQ:ZSAN), FirstMark Horizon Acquisition Corp. (NYSE:FMAC)  2021/11/27 00:11:07 Stock Equity
Zosano Pharma Corporation (ZSAN) with the stream of -0.50% also noticed, India FirstMark Horizon Acquisition Corp. (FMAC) encountered a rapid change of 0.00% in the last hour of Friday’s trading … The post Stock on the Move: Zosano Pharma Corporation (NASDAQ:ZSAN), FirstMark Horizon Acquisition Corp. (NYSE:FMAC) appeared first on Stocks Equity .
   Zosano Pharma Corporation (NASDAQ: ZSAN)s Stock Reduces -2.87%, Making It A Good Investment  2021/11/22 20:00:00 Stocks Register
The trading price of Zosano Pharma Corporation (NASDAQ:ZSAN) floating lower at last check on Monday, November 22, closing at $0.62, -2.87% lower than its previous close. >> 7 Top Picks for the Post-Pandemic Economy

 関連キーワード  (バイオテクノロジ―_メディカルリサ―チ 米国株 ゾサノ・ファ―マ ZSAN Zosano Pharma Corporation)

 twitter  (公式ツイッターやCEOツイッターなど)